<DOC>
	<DOCNO>NCT00338793</DOCNO>
	<brief_summary>Tuberculous pleurisy associate inflammation fibrosis . Adjunctive corticosteroid use tuberculous pleurisy anti-inflammatory effect think minimise pleural reactivity thereby reduce residual pleural thickening . The purpose evaluate efficacy safety oral prednisolone treatment adult patient tuberculous pleurisy .</brief_summary>
	<brief_title>Corticosteroids Treatment Tuberculous Pleurisy</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Pleurisy</mesh_term>
	<mesh_term>Tuberculosis , Pleural</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<criteria>Signed write informed consent ; Presented clinical feature suggest pleural tuberculosis ; Had previously receive treatment prophylaxis tuberculosis ; Had recently receive treatment glucocorticoid ; Were pregnant breastfeeding . Failed complete screening procedure ; Were seropositive HIV Tuberculous meningitis ; Had risk factor serious steroidrelated adverse event ( history diabetes positive urine glucose , history clinical finding hypertension , history peptic ulcer disease mental illness ) ; Standard dose antituberculosis drug could use ( participant concurrent liver disease ) Psychiatric illness ; Alcoholism .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Tuberculosis ;</keyword>
	<keyword>Pleural effusion ;</keyword>
	<keyword>Corticosteroids .</keyword>
</DOC>